{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:39:37Z","timestamp":1792445977627,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00520-026-11354-x","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:08:49Z","timestamp":1792400929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative efficacy of interventions for preventing chemotherapy-induced alopecia: a systematic review and network meta-analysis"],"prefix":"10.1007","volume":"34","author":[{"given":"Kansak","family":"Boonpattharatthiti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwapat","family":"Lawin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pongsapat","family":"Limhengsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teerapon","family":"Dhippayom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4309-4742","authenticated-orcid":false,"given":"Kwanjit","family":"Danwilai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"issue":"4","key":"11354_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70090","volume":"76","author":"H Sung","year":"2026","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2026) Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries. CA Cancer J Clin 76(4):e70090. https:\/\/doi.org\/10.3322\/caac.70090","journal-title":"CA Cancer J Clin"},{"key":"11354_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/tswj\/5056618","volume":"2025","author":"AM Oluwajembola","year":"2025","unstructured":"Oluwajembola AM, Zakari S, Cleanclay WD, Ayeni T, Adebosoye A, Okoh OS et al (2025) A review of novel cancer therapeutics and current research trends. ScientificWorldJournal 5056618. https:\/\/doi.org\/10.1155\/tswj\/5056618","journal-title":"ScientificWorldJournal"},{"issue":"8","key":"11354_CR3","first-page":"1218","volume":"47","author":"\u0130 Altun","year":"2018","unstructured":"Altun \u0130, Sonkaya A (2018) The most common side effects experienced by patients were receiving first cycle of chemotherapy. Iran J Public Health 47(8):1218\u20131219","journal-title":"Iran J Public Health"},{"issue":"18","key":"11354_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13185397","volume":"13","author":"K Mokbel","year":"2024","unstructured":"Mokbel K, Kodresko A, Trembley J, Jouhara H (2024) Therapeutic effect of superficial scalp hypothermia on chemotherapy-induced alopecia in breast cancer survivors. J Clin Med 13(18):5397. https:\/\/doi.org\/10.3390\/jcm13185397","journal-title":"J Clin Med"},{"issue":"5","key":"11354_CR5","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jaad.2018.03.055","volume":"80","author":"A Freites-Martinez","year":"2019","unstructured":"Freites-Martinez A, Shapiro J, Goldfarb S, Nangia J, Jimenez JJ, Paus R et al (2019) Hair disorders in patients with cancer. J Am Acad Dermatol 80(5):1179\u201396. https:\/\/doi.org\/10.1016\/j.jaad.2018.03.055","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"11354_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1471-6712.1992.tb00128.x","volume":"6","author":"AJ Tierney","year":"1992","unstructured":"Tierney AJ, Taylor J, Closs SJ (1992) Knowledge, expectations and experiences of patients receiving chemotherapy for breast cancer. Scand J Caring Sci 6(2):75\u201380. https:\/\/doi.org\/10.1111\/j.1471-6712.1992.tb00128.x","journal-title":"Scand J Caring Sci"},{"issue":"4","key":"11354_CR7","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.3390\/curroncol30040275","volume":"30","author":"TC Wikramanayake","year":"2023","unstructured":"Wikramanayake TC, Haberland NI, Akhundlu A, Laboy Nieves A, Miteva M (2023) Prevention and treatment of chemotherapy-induced alopecia: what is available and what is coming? Curr Oncol 30(4):3609\u20133626. https:\/\/doi.org\/10.3390\/curroncol30040275","journal-title":"Curr Oncol"},{"key":"11354_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.599073","volume":"10","author":"S Li","year":"2020","unstructured":"Li S, So TH, Tang G, Tan HY, Wang N, Ng BFL et al (2020) Chinese herbal medicine for reducing chemotherapy-associated side-effects in breast cancer patients: a systematic review and meta-analysis. Front Oncol 10:599073. https:\/\/doi.org\/10.3389\/fonc.2020.599073","journal-title":"Front Oncol"},{"key":"11354_CR9","unstructured":"U.S. Food and Drug Administration (2015) DigniCap scalp cooling system: evaluation of automatic class III designation - De Novo Request (DEN150010). https:\/\/www.accessdata.fda . gov\/cdrh_docs\/reviews\/DEN150010.pdf . Accessed 30 Nov 2025"},{"key":"11354_CR10","unstructured":"U.S. Food and Drug Administration (2017) Paxman Scalp Cooler: 510(k) premarket notification (K173032). https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf17\/K173032.pdf\n. Accessed 23 Aug 2026"},{"key":"11354_CR11","unstructured":"U.S. Food and Drug Administration (2021) Portable Scalp Cooling System: 510(k) premarket\u00a0notification (K211526).\u00a0Center for Devices and Radiological Health. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf21\/K211526.pdf. Accessed 23 Aug 2026"},{"issue":"6","key":"11354_CR12","doi-asserted-by":"publisher","first-page":"E567","DOI":"10.1097\/NCC.0000000000000899","volume":"44","author":"T Zhou","year":"2021","unstructured":"Zhou T, Han S, Zhu Z, Hu Y, Xing W (2021) Interventions for preventing chemotherapy-induced alopecia: a systematic review and network meta-analysis of randomized controlled trials. Cancer Nurs 44(6):E567\u2013E577. https:\/\/doi.org\/10.1097\/NCC.0000000000000899","journal-title":"Cancer Nurs"},{"issue":"5","key":"11354_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.abd.2020.03.005","volume":"95","author":"GB Silva","year":"2020","unstructured":"Silva GB, Ciccolini K, Donati A, Hurk CVD (2020) Scalp cooling to prevent chemotherapy-induced alopecia. An Bras Dermatol 95(5):631\u2013637. https:\/\/doi.org\/10.1016\/j.abd.2020.03.005","journal-title":"An Bras Dermatol"},{"key":"11354_CR14","unstructured":"Chaimani A, Caldwell DM, Li T, Higgins JPT, Salanti G (2024) Chapter 11: Undertaking network meta-analyses: Cochrane; https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/ handbook\/current\/chapter-11\/;2024. Accessed 30 Nov 202"},{"issue":"11","key":"11354_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C et al (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162(11):777\u2013784. https:\/\/doi.org\/10.7326\/M14-2385","journal-title":"Ann Intern Med"},{"key":"11354_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"1","key":"11354_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan-a web and mobile app for systematic reviews. Syst Rev 5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"11354_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"11354_CR19","unstructured":"McGuinness LA, Higgins JPT (2021) Risk-of-bias VISualization (robvis) tool Bristol (UK): University of Bristol, https:\/\/www.riskofbias.info\/welcome\/robvis-visualization-tool\/;2021. Accessed 30 Nov 2025"},{"issue":"6","key":"11354_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jama.2014.8166","volume":"312","author":"A Dechartres","year":"2014","unstructured":"Dechartres A, Altman DG, Trinquart L, Boutron I, Ravaud P (2014) Association between analytic strategy and estimates of treatment outcomes in meta-analyses. JAMA 312(6):623\u201330. https:\/\/doi.org\/10.1001\/jama.2014.8166","journal-title":"JAMA"},{"issue":"4","key":"11354_CR21","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1177\/1536867X1501500403","volume":"15","author":"IR White","year":"2015","unstructured":"White IR (2015) Network meta-analysis. Stata J 15(4):951\u2013985","journal-title":"Stata J"},{"issue":"4","key":"11354_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003082","volume":"17","author":"A Nikolakopoulou","year":"2020","unstructured":"Nikolakopoulou A, Higgins JPT, Papakonstantinou T, Chaimani A, Del Giovane C, Egger M et al (2020) CINeMA: an approach for assessing confidence in the results of a network meta-analysis. PLoS Med 17(4):e1003082. https:\/\/doi.org\/10.1371\/journal.pmed.1003082","journal-title":"PLoS Med"},{"key":"11354_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.breast.2019.12.004","volume":"49","author":"J Bajpai","year":"2020","unstructured":"Bajpai J, Kagwade S, Chandrasekharan A, Dandekar S, Kanan S, Kembhavi Y et al (2020) Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia. Breast 49:187\u2013193. https:\/\/doi.org\/10.1016\/j.breast.2019.12.004","journal-title":"Breast"},{"issue":"7","key":"11354_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08579-z","volume":"32","author":"E Carton","year":"2024","unstructured":"Carton E, Blas AM, Perret C, Le Bihan M (2024) Effectiveness of increasing the scalp cooling duration to prevent alopecia during adjuvant chemotherapy for breast cancer: a randomized pilot study. Support Care Cancer 32(7):410. https:\/\/doi.org\/10.1007\/s00520-024-08579-z","journal-title":"Support Care Cancer"},{"issue":"3","key":"11354_CR25","first-page":"170","volume":"11","author":"G Giaccone","year":"1988","unstructured":"Giaccone G, Di Giulio F, Morandini MP, Calciati A (1988) Scalp hypothermia in the prevention of doxorubicin-induced hair loss. Cancer Nurs 11(3):170\u2013173","journal-title":"Cancer Nurs"},{"issue":"5","key":"11354_CR26","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00520-018-4432-6","volume":"27","author":"MMC Komen","year":"2019","unstructured":"Komen MMC, van den Hurk CJG, Nortier JWR, van der Ploeg T, Nieboer P, van der Hoeven JJM et al (2019) Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy. Support Care Cancer 27(5):1919\u201325. https:\/\/doi.org\/10.1007\/s00520-018-4432-6","journal-title":"Support Care Cancer"},{"key":"11354_CR27","doi-asserted-by":"crossref","unstructured":"LOVEJOY NCRN, M.S (1979) Preventing hair loss during adriamycin therapy. Cancer Nurs 2(2):117 - 21","DOI":"10.1097\/00002820-197904000-00005"},{"key":"11354_CR28","doi-asserted-by":"publisher","unstructured":"Nangia JR, Wang T, Osborne CRC, Niravath PA, Otte K, Papish SW et al (2017) Scalp Cooling Alopecia Prevention trial (SCALP) for patients with early stage breast cancer. J Clin Oncol 35(15_suppl).\u00a0https:\/\/doi.org\/10.1200\/JCO.2017.35.15_suppl.10088","DOI":"10.1200\/JCO.2017.35.15_suppl.10088"},{"issue":"8","key":"11354_CR29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/oxfordjournals.annonc.a058986","volume":"5","author":"R Rodriguez","year":"1994","unstructured":"Rodriguez R, Machiavelli M, Leone B, Romero A, Cuevas MA, Langhi M et al (1994) Minoxidil (Mx) as a prophylaxis of doxorubicin- -induced alopecia. Ann Oncol 5(8):769\u201370. https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a058986","journal-title":"Ann Oncol"},{"key":"11354_CR30","doi-asserted-by":"publisher","unstructured":"Satterwhite B, Zimm S (1984) The use of scalp hypothermia in the prevention of doxorubicin-induced hair loss. Cancer 54(1):34\u201337. https:\/\/doi.org\/10.1002\/1097-0142(19840701)54:","DOI":"10.1002\/1097-0142(19840701)54:"},{"issue":"9","key":"11354_CR31","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1200\/JCO.1995.13.9.2342","volume":"13","author":"B Sredni","year":"1995","unstructured":"Sredni B, Albeck M, Tichler T, Shani A, Shapira J, Bruderman I et al (1995) Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide. J Clin Oncol 13(9):2342\u20132353. https:\/\/doi.org\/10.1200\/JCO.1995.13.9.2342","journal-title":"J Clin Oncol"},{"issue":"1","key":"11354_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/(SICI)1097-0215(19960103)65:1<97::AID-IJC17>3.0.CO;2-F","volume":"65","author":"B Sredni","year":"1996","unstructured":"Sredni B, Xu RH, Albeck M, Gafter U, Gal R, Shani A et al (1996) The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models. Int J Cancer 65(1):97\u2013103. https:\/\/doi.org\/10.1002\/(SICI)1097-0215(19960103)65:1<97::AID-IJC17>3.0.CO;2-F","journal-title":"Int J Cancer"},{"issue":"6","key":"11354_CR33","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1177\/0300060519842781","volume":"47","author":"F Yu","year":"2019","unstructured":"Yu F, Li Y, Zou J, Jiang L, Wang C, Tang Y et al (2019) The Chinese herb Xiaoaiping protects against breast cancer chemotherapy-induced alopecia and other side effects: a randomized controlled trial. J Int Med Res 47(6):2607\u20132614","journal-title":"J Int Med Res"},{"issue":"6","key":"11354_CR34","first-page":"487","volume":"8","author":"YL He","year":"2005","unstructured":"He YL, Deng YH, Huang MJ, Zhao JZ, Cai SR, Zhang CH et al (2005) Protective efficacy and probable mechanism of ulinastatin in patients with gastrointestinal cancer undergoing adjuvant chemotherapy. Zhonghua Wei Chang Wai Ke Za Zhi 8(6):487\u2013489","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"11354_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ygyno.2024.06.012","volume":"188","author":"KA Lambert","year":"2024","unstructured":"Lambert KA, Albright BB, Anastasio MK, Kaplan SJ, McNally L (2024) Scalp hypothermia to reduce chemotherapy-induced alopecia: a systematic review and meta-analysis. Gynecol Oncol 188:71\u201380. https:\/\/doi.org\/10.1016\/j.ygyno.2024.06.012","journal-title":"Gynecol Oncol"},{"issue":"11","key":"11354_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-025-10058-y","volume":"33","author":"L Kaufman","year":"2025","unstructured":"Kaufman L, Valentic L, Malley L, Icksarus C, Rose L, Dulmage B (2025) Scalp cooling therapy in chemotherapy-induced alopecia: addressing variability in cooling duration and efficacy. Support Care Cancer 33(11):1005. https:\/\/doi.org\/10.1007\/s00520-025-10058-y","journal-title":"Support Care Cancer"},{"key":"11354_CR37","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) (2025): Breast Cancer, https:\/\/www.nccn.org\/professionals\/physician_gls\/ pdf\/breast.pdf\/; Accessed 5 Dec 2025"},{"key":"11354_CR38","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) (2025): Ovarian Cancer (Including Fallopian Tube Cancer and Primary Peritoneal Cancer), https:\/\/www.nccn.org\/professionals\/ physician_gls\/pdf\/ovarian.pdf\/;2025. Accessed 5 Dec 2025"},{"key":"11354_CR39","unstructured":"WMEAGfSA-CT\u00a0(SACT) (2017) Scalp cooling guidelines for adult oncology patients. NHS England, 11 p"},{"key":"11354_CR40","unstructured":"Scalp Cooling \u2013 a guide for patient (2025) https:\/\/www.ulh.nhs.uk\/patients\/patient-information-library\/scalp-cooling-a-guide-for-patients\/;2025. Accessed 5 Dec 2025"},{"issue":"1","key":"11354_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-44772-2","volume":"16","author":"ST Kwok","year":"2026","unstructured":"Kwok ST, Lau LSK, Chan TO, Chu MMY, Ngu SF, Chan KKL et al (2026) The efficacy of scalp cooling in patients receiving chemotherapy for primary gynecologic cancers: a randomized controlled trial. Sci Rep 16(1):14109. https:\/\/doi.org\/10.1038\/s41598-026-44772-2","journal-title":"Sci Rep"},{"key":"11354_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2026.104784","volume":"87","author":"J Zhang","year":"2026","unstructured":"Zhang J, Wang L, He Y, Sun H, Niu J, Duan M et al (2026) Efficacy of scalp cooling system versus chemical cooling cap in preventing chemotherapy-induced alopecia in breast cancer (COHAIR study): a prospective randomized trial. Breast 87:104784. https:\/\/doi.org\/10.1016\/j.breast.2026.104784","journal-title":"Breast"},{"issue":"1","key":"11354_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-025-04577-7","volume":"40","author":"M Claes","year":"2025","unstructured":"Claes M, Robijns J, Lambrichts L, Van Duffel S, Bulens P, Mebis J (2025) Photobiomodulation therapy in the prevention of chemotherapy-induced alopecia in breast cancer patients: a randomized controlled trial. Lasers Med Sci 40(1):325. https:\/\/doi.org\/10.1007\/s10103-025-04577-7","journal-title":"Lasers Med Sci"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11354-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11354-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11354-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:01:49Z","timestamp":1792443709000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11354-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["11354"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11354-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No human\/animal research; subsequently, no informed consents needed.","order":1,"name":"Ethics","label":"Human and animal rights and informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1123"}}